Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice.

Crettaz J, Berraondo P, Mauleón I, Ochoa-Callejero L, Shankar V, Barajas M, van Rooijen N, Kochanek S, Qian C, Prieto J, Hernández-Alcoceba R, González-Aseguinolaza G.

Hepatology. 2006 Sep;44(3):623-32. Erratum in: Hepatology. 2011 Dec;54(6):2280. Ochoa, Laura [corrected to Ochoa-Callejero, L].

PMID:
16941711
2.

Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.

Benihoud K, Esselin S, Descamps D, Jullienne B, Salone B, Bobé P, Bonardelle D, Connault E, Opolon P, Saggio I, Perricaudet M.

Gene Ther. 2007 Mar;14(6):533-44. Epub 2006 Nov 16. Erratum in: Gene Ther. 2007 Mar;14(6):551.

PMID:
17109009
3.

Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.

Yoon SK, Armentano D, Wands JR, Mohr L.

Cancer Gene Ther. 2001 Aug;8(8):573-9.

4.

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver.

Tao N, Gao GP, Parr M, Johnston J, Baradet T, Wilson JM, Barsoum J, Fawell SE.

Mol Ther. 2001 Jan;3(1):28-35.

5.

Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.

Mitchell M, Jerebtsova M, Batshaw ML, Newman K, Ye X.

Gene Ther. 2000 Dec;7(23):1986-92.

7.

Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.

Rawle FE, Shi CX, Brown B, McKinven A, Tinlin S, Graham FL, Hough C, Lillicrap D.

J Gene Med. 2004 Dec;6(12):1358-68.

PMID:
15493040
8.

Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.

Kuriyama S, Yoshiji H, Nakai S, Deguchi A, Uchida N, Kimura Y, Inoue H, Kinekawa F, Ogawa M, Nonomura T, Masaki T, Kurokohchi K, Watanabe S.

Oncol Rep. 2005 Jan;13(1):69-74.

PMID:
15583804
9.

Effect of BMP-2 gene transfer on bone healing in sheep.

Egermann M, Lill CA, Griesbeck K, Evans CH, Robbins PD, Schneider E, Baltzer AW.

Gene Ther. 2006 Sep;13(17):1290-9. Epub 2006 Apr 27.

PMID:
16642029
10.

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.

Chuah MK, Schiedner G, Thorrez L, Brown B, Johnston M, Gillijns V, Hertel S, Van Rooijen N, Lillicrap D, Collen D, VandenDriessche T, Kochanek S.

Blood. 2003 Mar 1;101(5):1734-43. Epub 2002 Oct 24.

11.

Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.

Yao X, Yoshioka Y, Morishige T, Eto Y, Narimatsu S, Mizuguchi H, Mukai Y, Okada N, Nakagawa S.

Biol Pharm Bull. 2010;33(6):1073-6.

12.
13.

Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.

Gu DL, Gonzalez AM, Printz MA, Doukas J, Ying W, D'Andrea M, Hoganson DK, Curiel DT, Douglas JT, Sosnowski BA, Baird A, Aukerman SL, Pierce GF.

Cancer Res. 1999 Jun 1;59(11):2608-14.

14.

Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.

Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, Indelicato S, Jacobs S, Kolz K, Maneval D, Musco ML, Shinoda J, Venook A, Wen S, Warren R.

Cancer Gene Ther. 2006 Feb;13(2):169-81.

PMID:
16082381
15.

Factors influencing retention of adenovirus within tumours following direct intratumoural injection.

Bazan-Peregrino M, Carlisle RC, Purdie L, Seymour LW.

Gene Ther. 2008 May;15(9):688-94. doi: 10.1038/gt.2008.2. Epub 2008 Feb 21.

PMID:
18288207
17.

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.

Fechner H, Haack A, Wang H, Wang X, Eizema K, Pauschinger M, Schoemaker R, Veghel R, Houtsmuller A, Schultheiss HP, Lamers J, Poller W.

Gene Ther. 1999 Sep;6(9):1520-35.

18.

A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.

Riezebos-Brilman A, Walczak M, Regts J, Rots MG, Kamps G, Dontje B, Haisma HY, Wilschut J, Daemen T.

Gene Ther. 2007 Dec;14(24):1695-704. Epub 2007 Oct 11.

PMID:
17928874
19.

Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis.

Epperly MW, Bray JA, Krager S, Berry LM, Gooding W, Engelhardt JF, Zwacka R, Travis EL, Greenberger JS.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):169-81.

PMID:
9989524
20.

Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.

Muruve DA, Cotter MJ, Zaiss AK, White LR, Liu Q, Chan T, Clark SA, Ross PJ, Meulenbroek RA, Maelandsmo GM, Parks RJ.

J Virol. 2004 Jun;78(11):5966-72.

Supplemental Content

Support Center